tiprankstipranks
Alphamab Oncology (HK:9966)
HKEX:9966
Hong Kong Market
Holding HK:9966?
Track your performance easily

Alphamab Oncology (9966) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Alphamab Oncology’s (9966) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting Alphamab Oncology is a Buy.
Alphamab Oncology’s (9966) 20-Day exponential moving average is 4.30, while Alphamab Oncology’s (9966) share price is HK$4.32, making it a Buy.
Alphamab Oncology’s (9966) 50-Day exponential moving average is 3.88, while Alphamab Oncology’s (9966) share price is HK$4.32, making it a Buy.

Alphamab Oncology (9966) Pivot Points

Nov 27, 2024, 05:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.86
4.07
4.22
4.43
4.58
4.79
4.94
Fibonacci
4.07
4.21
4.30
4.43
4.57
4.66
4.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Alphamab Oncology (9966) Moving Averages

Nov 27, 2024, 05:11 AM
Period
Simple
Exponential
MA5
4.47Sell
4.44Sell
MA10
4.56Sell
4.43Sell
MA20
4.24Buy
4.30Buy
MA50
3.84Buy
3.88Buy
MA100
3.09Buy
3.63Buy
MA200
3.65Buy
4.06Buy
Alphamab Oncology’s (9966) 10-Day exponential moving average is 4.43, while Alphamab Oncology’s (9966) share price is HK$4.32, making it a Sell.
Alphamab Oncology’s (9966) 100-Day exponential moving average is 3.63, while Alphamab Oncology’s (9966) share price is HK$4.32, making it a Buy.
Alphamab Oncology’s (9966) stock price is HK$4.32 and Alphamab Oncology’s (9966) 50-day simple moving average is 3.84, creating a Buy signal.
Alphamab Oncology’s (9966) stock price is HK$4.32 and Alphamab Oncology’s (9966) 100-day simple moving average is 3.09, creating a Buy signal.
Alphamab Oncology’s (9966) stock price is HK$4.32 and Alphamab Oncology’s (9966) 200-day simple moving average is 3.65, creating a Buy signal.

Alphamab Oncology (9966) Technical Indicators

Nov 27, 2024, 05:11 AM
Name
Value
Implied Action
RSI (14)
53.65
Neutral
STOCH (9,6)
20.45
Neutral
STOCHRSI (14)
49.63
Neutral
MACD (12,26)
0.20
Buy
ADX (14)
31.04
Neutral
Williams %R
-58.39
Buy
CCI (14)
20.90
Neutral
ATR (14)
0.30
-
Ultimate Oscillator
39.44
Neutral
ROC
11.63
Buy
Alphamab Oncology’s (9966) Relative Strength Index (RSI) is 53.65, creating a Neutral signal.
Alphamab Oncology’s (9966) Trend Strength Indicator (ADX) is 31.04, creating a Neutral signal.
Alphamab Oncology’s (9966) Commodity Channel Index (CCI) is 20.90, creating a Neutral signal.
Alphamab Oncology’s (9966) Price Rate of Change (ROC) is 11.63, creating a Buy signal.

FAQ

Is 9966 a Buy, Hold, or Sell?
Based on 9966’s technical indicators, 9966 is a Buy.
    What is 9966’s RSI (14)?
    9966’s RSI (14) is 53.65, which suggests 9966 is a Neutral.
      What is 9966’s MACD?
      9966’s MACD is 0.20, which suggests 9966 is a Buy.
        What is 9966’s 5-day moving average?
        9966’s 5-day moving average is 4.47, which suggests 9966 is a Sell.
          What is 9966’s 20-day moving average?
          9966 20-day moving average is 4.24, which suggests 9966 is a Buy.
            What is 9966’s 50-day moving average?
            9966’s 50-day moving average is 3.84, which suggests 9966 is a Buy.
              What is 9966’s 200-day moving average?
              9966’s 200-day moving average is 3.65, which suggests 9966 is a Buy.
                What is 9966’s Williams % R (14)?
                9966’s Williams % R (14) is -58.39, which suggests 9966 is a Buy.
                  What is 9966’s CCI (14)?
                  9966’s CCI (14) is 20.90, which suggests 9966 is a Neutral.
                    What is the share price of Alphamab Oncology?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis